Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-28

Clinical Trial Update: Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) [Phase 3]

View source ↗

Summary

Phase 3 trial update on seasonal malaria vaccination (RTS,S/AS01) and seasonal malaria chemoprevention (SP/AQ) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RTS,S/AS01 (RTS,S/AS01)
  • SP/AQ (sulfadoxine-pyrimethamine and amodiaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria,Falciparum, Children, Only | Phase 3 | Status: COMPLETED | Results posted: 2022-01-28